Highlights Fulgent Genetics, Inc.

Equities

FLGT

US3596641098

Real-time Estimate Cboe BZX Other stock markets 11:30:48 13/05/2024 pm IST			5-day change	1st Jan Change
22.45 ^USD	+3.22%		+3.54%	-23.04%

03/05	Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024
03/05	Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M	03/05	MT
Fulgent Genetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	03/05	CI
Fulgent Genetics, Inc. Reiterates Earnings Guidance for the Year 2024	03/05	CI
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022.	29/02	CI
Fulgent Genetics, Inc. Provides Earnings Guidance for the Year 2024	28/02	CI
Fulgent Genetics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28/02	CI
Earnings Flash (FLGT) FULGENT GENETICS Reports Q4 Revenue $70.5M	28/02	MT
Earnings Flash (FLGT) FULGENT GENETICS Reports Q4 EPS $0.28	28/02	MT
Cooper Unit, Fulgent Genetic to Offer Newborn Genetic Screening Panels	09/02	MT
Cord Blood Registry by CooperSurgical, Inc. and Fulgent Genetics, Inc. Launch Innovative Genetic Testing	09/02	CI
Fulgent Genetics, Inc. Announces Two Poster Presentations At SITC 2023 Annual Meeting	04/11	CI
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022.	03/11	CI
Fulgent Genetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03/11	CI
Fulgent Genetics, Inc. Reiterates Earnings Guidance for the Full Year 2023	03/11	CI
Fulgent Genetics Swings to Loss in Q2, Revenue Declines; Raises Guidance; Shares Surge 10% Pre-Bell	04/23/04	MT
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022.	04/23/04	CI
Fulgent Genetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04/23/04	CI
Fulgent Genetics, Inc. Provides Earnings Guidance for the Third Quarter of 2023 and Full Year 2023	04/23/04	CI
Fulgent Genetics, Inc. Announces Data from a Phase 1/1b Clinical Study of FID-007 in Treating Various Solid Tancers	05/23/05	CI
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022.	05/23/05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Fulgent Genetics, Inc.

Equities

FLGT

US3596641098

Highlights

Filters